Stock Ratings / Health Care / MD / earnings

BKD (46) SGRY (66) ARDT (67) NHC (69) ⌘ Pro Terminal →

Pediatrix Medical Group Inc. (MD) Next Earnings Date & Expected ±6.7% Move

$29.18 +0.93% NYSE • Live Quote vs Prior Daily Close (Synced Snapshot)

Pediatrix Medical Group Inc. (MD) earns a Roarable Rating of B (Buy) with 74/100 RQD Confidence. High-quality cash engine (steady margins, 34% return on capital) with steady institutional support. The company’s underlying cash engine and institutional positioning keep the composite score in the Green Buy zone.

ROARABLE B • BUY Cap $2.37B

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

RQD QUANT TACHOMETERBUY • B

2-of-3 JEV AI Jury Bullish

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw B · Rk B

Each axis scored 0–20

12M PRICE TARGET CONE+7.2% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for MD)Realized 20D OHLCV Swing Band: ±6.7%

NEXT EST. WINDOW: Dec 30, 2026 (~58 DAYS)

Historical OHLCV Volatility ±6.7% Swing Band

±$1.96 Expected Swing

MODEL EARNINGS SETUP GAUGE

MD Quantitative Pre-Earnings Setup: 74/100

Trailing EPS: $2.04 • YoY Revenue Growth: 12.4%

Model Bullish Setup (74/100)Model Risk Weight (26/100)

Derived deterministically from RQD cash-flow quality, SEC accrual safety, and institutional flow (not a community poll).

LOG YOUR PERSONAL PRE-EARNINGS STANCE (SAVED LOCALLY IN BROWSER):

Recent SEC Reported Revenue, Net Profit & Diluted EPS Cadence

Period	Filed	Revenue	Net Profit	Free Cash Flow	Gross Margin
FY 2025	2025-12-31	$0	$165.4M	$271.1M	52%
FY 2024	2024-12-31	$0	-$99.1M	$206.6M	52%
FY 2023	2023-12-31	$0	-$60.4M	$137.3M	52%

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher + Options & Swing Structure Desk

Whale Flow & Momentum Playbook: Evaluating MD & AI Leaders Without Chasing Tops

✓Institutional whale strikes & implied earnings move audit on MD
✓How disciplined traders manage risk using pre-published trigger & invalidation levels
✓Includes nightly RQD rating-change & forensic signal email alerts on tracked leaders

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

MD // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +29.63%▲ ASCENDING CHANNEL

2026-10-30O $29.48H $29.97L $29.07C $29.18VOL 1.11M

RES: $30.35SUP: $25.55SMA50: $26.93SMA200: $23.87

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

MD Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 MD Butterfly Map → + Track MD →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

6.2%/yr Implied 5Y Growth

vs. +6.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on MD today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for MD. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for MD today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (MD)

Health Care Rank #53 of 1016 ⚔️ BKD vs MD Full Matrix →

1. Head-to-Head Health Care Peer Comparison (MD vs. BKD, SGRY, ARDT, NHC)

Industry: Hospital/Nursing Management (14 Tracked Issuers)

Across 1016 tracked Health Care securities in the Roarable RQD universe, Pediatrix Medical Group Inc. (MD) ranks #53 by composite RQD confidence (74/100, grade B) and #228 by equity capitalization ($2.37B). Within this direct 5-issuer industry benchmark cohort, ARDT leads on earnings valuation at 12.8x trailing P/E, while MD leads on capital efficiency and profitability with 33.6% ROIC and — gross margin. MD currently leads its immediate peer cohort in composite quantitative strength at 74/100 (B).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
MD ACTIVE Pediatrix Medical Group Inc.	B	74/100	14.3x	—	33.6%	+0.93%	$2.37B	Benchmark Subject
BKD Brookdale Senior Living Inc.	D	46/100	—	26.2%	0.3%	+2.91%	$2.45B	/bkd-vs-md →
SGRY Surgery Partners Inc.	C+	66/100	—	—	9.9%	-0.13%	$3.04B	/sgry-vs-md →
ARDT Ardent Health Inc.	C+	67/100	12.8x	—	10.5%	+3.10%	$1.73B	/ardt-vs-md →
NHC National HealthCare Corporation	C+	69/100	27.7x	—	10.1%	+0.18%	$3.32B	/nhc-vs-md →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0000893949

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Pediatrix Medical Group Inc. (MD) reported GAAP revenue of $0 (N/A vs. FY2024 revenue of $0 ) , GAAP net income of $165.4M, operating cash flow of $271.1M, and free cash flow of $271.1M (+31.2% YoY). On the balance sheet, MD closed FY2025 with $2.25B in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: 6/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$0	$165.4M	$271.1M	$271.1M	$2.25B	—
FY2024 (FY)	2024-12-31	$0	-$99.1M	$206.6M	$206.6M	$2.15B	—
FY2023 (FY)	2023-12-31	$0	-$60.4M	$137.3M	$137.3M	—	—

3. MD Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is MD stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, Pediatrix Medical Group Inc. (NYSE: MD) is rated B (Buy / BUY) by Roarable's 5-pillar RQD engine with a composite confidence score of 74/100 at a spot price of $29.18 (+0.93% 1D, market cap $2.37B). Pillar breakdown: Fundamental Cash Engine 16/20, Institutional 13F & Options Flow 12/20, Executive Insider Alignment 13/20, FRED Macro Regime Fit 16/20, and SEC Balance-Sheet Forensics 17/20. Across 1016 tracked Health Care issuers, MD ranks #53 in composite RQD confidence.

How does MD compare to BKD and SGRY in the Health Care sector?

Within the Health Care sector (Hospital/Nursing Management), MD carries a Roarable B (74/100 RQD), trailing P/E of 14.3x, gross margin of —, and ROIC of 33.6%. By comparison, BKD (Brookdale Senior Living Inc.) holds a D grade (46/100 RQD, P/E N/A, ROIC 0.3%, cap $2.45B) and SGRY (Surgery Partners Inc.) posts a C+ grade (66/100 RQD, P/E N/A, ROIC 9.9%, cap $3.04B). Among the 5-stock peer group, ARDT leads on earnings multiple (12.8x) while MD leads on capital efficiency (33.6% ROIC).

What are the biggest fundamental strengths and SEC risk factors for MD?

Per MD's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0000893949), Pediatrix Medical Group Inc. generated $0 in revenue, $165.4M in net income, and $271.1M in free cash flow against $2.25B in total assets and $0 in total debt. Key quantitative strengths: Strong cash generator (steady margins)—profits are backed by real money, not accounting tricks.. Primary risk factors monitored: Broader market pullbacks can still drag down strong stocks in the short run.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is MD trading relative to its 50-day, 200-day, and 52-week technical levels?

MD last traded at $29.18 (+0.93% on volume of 832,584 shares), positioning the stock +8.35% above its 50-day simple moving average ($26.93) and +22.25% above its 200-day simple moving average ($23.87). Across its 52-week range of $17.23 to $30.55, MD sits at the 89.7% percentile with a 14-day RSI of 71.7 (OVERBOUGHT (>70)) and an implied next-earnings move of ±6.7% ($27.22 to $31.14).

MD Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

When is MD's next earnings date?

Based on SEC filing cadence, Pediatrix Medical Group Inc. (MD)'s next quarterly reporting window is estimated around Dec 30, 2026.

How much is MD stock expected to move on earnings?

Volatility modeling currently projects a ±6.7% event move for MD, spanning a range between $27.22 and $31.14.

Direct Sub-Reports: MD RQD Cockpit MD 12M Forecast MD Earnings & Move MD Dividends & DRIP MD Insiders & 13F MD Whale Options MD Profit Sankey MD News & Why